Developments in Intralesional Therapy for Metastatic Melanoma (Q28069615)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009452%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

title

Developments in Intralesional Therapy for Metastatic Melanoma (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009452%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009452%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Sarah Sloot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009452%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Arnod A Sarnaik

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009452%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Jonathan S Zager

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009452%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

language of work or name

1 reference

1 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009452%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009452%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009452%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009452%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

page(s)

12-20

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009452%20AND%20SRC:MED&resulttype=core&format=json

New viruses for cancer therapy: meeting clinical needs

30 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Intralesional therapy for advanced melanoma: promise and limitation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Intralesional therapy for metastatic melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Locoregional therapies in melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Treatment of in-transit melanoma with intra-lesional interleukin-2: a systematic review.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Intralesional therapy with PV-10 (Rose Bengal) for in-transit melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Intralesional immunotherapy for melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Intralesional injection of rose bengal induces a systemic tumor-specific immune response in murine models of melanoma and breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Microinvasive melanoma: cutaneous pharmacotherapeutic approaches.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Combined intralesional Bacille Calmette-Guérin (BCG) and topical imiquimod for in-transit melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Local and intralesional therapy of in-transit melanoma metastases

29 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

29 September 2017

https://api.crossref.org/works/10.1177%2F107327481602300104

Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Long-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

A review of recent findings involving interleukin-2-based cancer therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Intralesional granulocyte-monocyte colony-stimulating factor followed by subcutaneous interleukin-2 in metastatic melanoma: a pilot study in elderly patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

The therapeutic use of topical contact sensitizers in benign dermatoses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Immunotherapy of malignancy by in vivo gene transfer into tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Current status of interleukin-2 therapy in cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Risks of BCG intralesional therapy: An experience with melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Intralesional BCG, intravenous immune lymphocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; A clinical assessment

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guérin and hyperthermic perfusion

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma

2 June 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300104

High response rate after intratumoral treatment with interleukin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300104

Phase 2 trial of Allovectin-7 in advanced metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300104

Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300104

Topical imiquimod and intralesional interleukin-2 increase activated lymphocytes and restore the Th1/Th2 balance in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300104

Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300104

Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300104

Novel use of Rose Bengal (PV-10) in two cases of refractory scalp sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300104

Topical diphencyprone immunotherapy for cutaneous metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300104

Topical imiquimod immunotherapy in the management of lentigo maligna

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300104

Imiquimod use in the treatment of lentigo maligna

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300104

A phase 2 study of high-dose Allovectin-7 in patients with advanced metastatic melanoma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Treatment of locally metastatic melanoma: a novel approach.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4904721

Clinical responses and lymphoid infiltrates in metastatic melanoma following treatment with intralesional GM-CSF

27 November 2018

1 reference

12 December 2020

A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series

1 reference

12 December 2020

[Experience in the treatment of cutaneous in-transit melanoma metastases and satellitosis with intralesional interleukin-2]

1 reference

12 December 2020

Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy)

1 reference

12 December 2020

Chemoablation of metastatic melanoma using intralesional Rose Bengal

1 reference

12 December 2020

BCG immunotherapy in patients with malignant melanoma

1 reference

12 December 2020

Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma

1 reference

12 December 2020

Topical immunotherapy of alopecia areata

1 reference

12 December 2020

Intra-lesional interleukin-2 for the treatment of in-transit melanoma

1 reference

12 December 2020

Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma

1 reference

12 December 2020

Hypotension and disseminated intravascular coagulation following intralesional bacillus Calmette-Guérin therapy for locally metastatic melanoma

1 reference

12 December 2020

Topical diphencyprone immunotherapy for a large primary melanoma on an elderly leg

1 reference

12 December 2020

Intralesional injection of interleukin-2-expanded autologous lymphocytes in melanoma and breast cancer patients: a pilot study

1 reference

12 December 2020

Allovectin-7 therapy in metastatic melanoma

1 reference

12 December 2020

Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma

1 reference

12 December 2020

Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone

1 reference

12 December 2020

Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil

1 reference

12 December 2020

10.1177/107327481602300104

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009452%20AND%20SRC:MED&resulttype=core&format=json

OpenCitations bibliographic resource ID

30 March 2020

3145682

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009452%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

PubMed publication ID

27009452

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3145682

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009452%20AND%20SRC:MED&resulttype=core&format=json